市場調查報告書
商品編碼
1423211
2024-2032 年按產品類型、材料、手術類型、適應症和地區分類的心血管植入物市場報告Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2024-2032 |
2023年,全球心血管植入物市場規模達到2,61億美元。展望未來, IMARC Group預計到2032年市場規模將達到433億美元,2024-2032年複合年成長率(CAGR)為5.6%。心血管疾病盛行率上升、老年人口不斷擴大以及醫療保健產業的顯著進步是推動市場發展的一些關鍵因素。
心血管植入物是用於治療各種心血管疾病(CVD)的專用醫療工具,包括心臟衰竭、冠狀動脈疾病、週邊動脈疾病、主動脈疾病和心肌梗塞。它們安裝在體內,以支持心臟和血管的正常功能,並減輕與心律異常相關的症狀。這些設備由鈦、熱解碳、矽膠和塑膠網製成,並配備植入式心律轉復除顫器 (ICD) 產生器和聚氨酯 (PU) 聚合物絕緣的電線。心血管植入物可以檢測嚴重的心律並發送訊號以維持正常的心臟功能。
The global cardiovascular implants market size reached US$ 26.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 43.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The rising prevalence of cardiovascular diseases, the expanding geriatric population, and significant advancements in the healthcare sector represent some of the key factors driving the market.
Cardiovascular implants are specialized medical tools used to treat various cardiovascular diseases (CVDs), including heart failure, coronary artery disease, peripheral arterial disease, aortic disease, and myocardial infarction. They are fitted inside the body to support the proper functioning of the heart and blood vessels and to alleviate symptoms associated with abnormal heart rhythms. These devices are made from titanium, pyrolytic carbon, silicone, and plastic mesh and are equipped with an implantable cardioverter-defibrillator (ICD) generator and wires that are insulated with polyurethane (PU) polymer. Cardiovascular implants can detect severe heart rhythms and send signals to maintain normal heart function.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiovascular implants market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, material, procedure type and indication.
Coronary Stent
ICD
Heart Valve
Implanted Cardiac Pacemaker
CRT Device
Peripheral Stent
The report has provided a detailed breakup and analysis of the cardiovascular implants market based on the product type. This includes coronary stent, ICD, heart valve, implanted cardiac pacemaker, CRT device, and peripheral stent. According to the report, ICD represented the largest segment.
Metals and Alloys
Polymers
Biological Materials
A detailed breakup and analysis of the cardiovascular implants market based on the material has also been provided in the report. This includes metals and alloys, polymers, and biological materials.
Angioplasty
Open Heart Surgery
The report has provided a detailed breakup and analysis of the cardiovascular implants market based on the procedure type. This includes angioplasty and open heart surgery.
Arrhythmias
Myocardial Ischemia
Acute Myocardial Infarction
Congestive Heart Failure
Others
A detailed breakup and analysis of the cardiovascular implants market based on the indication type has also been provided in the report. This includes arrhythmias, myocardial ischemia, acute myocardial infarction, congestive heart failure, and others. According to the report, arrhythmias accounted for the largest market share.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for cardiovascular implants. Some of the factors driving the North America cardiovascular implants market included the rising prevalence of CVDs, innovative product advancements, and the growing geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global cardiovascular implants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include BIOTRONIK SE & Co. KG, Abbott Laboratories, AMG International, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation, Edwards Lifesciences Corporation, Fortimedix Surgical B.V., Neovasc Inc., CryoLife Inc., Proxy Biomedical Ltd., REVA Medical, LLC., and Shree Pacetronix Ltd.